<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK195854" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK195854/" /><meta name="ncbi_pagename" content="RRM2B-Related Mitochondrial Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>RRM2B-Related Mitochondrial Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="RRM2B-Related Mitochondrial Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/04/17" /><meta name="citation_author" content="Gráinne S Gorman" /><meta name="citation_author" content="Robert W Taylor" /><meta name="citation_pmid" content="24741716" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK195854/" /><meta name="citation_keywords" content="Chronic Progressive External Ophthalmoplegia with Multiple mtDNA Deletions" /><meta name="citation_keywords" content="Mitochondrial DNA Depletion Syndrome (Encephalomyopathic Form with Renal Tubulopathy)" /><meta name="citation_keywords" content="Mitochondrial Neurogastrointestinal Encephalopathy" /><meta name="citation_keywords" content="Ribonucleoside-diphosphate reductase subunit M2 B" /><meta name="citation_keywords" content="RRM2B" /><meta name="citation_keywords" content="RRM2B-Related Mitochondrial Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="RRM2B-Related Mitochondrial Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Gráinne S Gorman" /><meta name="DC.Contributor" content="Robert W Taylor" /><meta name="DC.Date" content="2014/04/17" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK195854/" /><meta name="description" content="RRM2B-related mitochondrial disease can be grouped by disease pathogenesis, phenotype, and mode of inheritance into two major types: mitochondrial DNA (mtDNA) depletion and multiple mtDNA deletions." /><meta name="og:title" content="RRM2B-Related Mitochondrial Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="RRM2B-related mitochondrial disease can be grouped by disease pathogenesis, phenotype, and mode of inheritance into two major types: mitochondrial DNA (mtDNA) depletion and multiple mtDNA deletions." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK195854/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/rrm2b-mtddepl/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK195854/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B9934E0402BA10000000006050233.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK195854_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK195854_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rpe65-lca/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/refsum/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK195854_"><span class="title" itemprop="name"><i>RRM2B</i>-Related Mitochondrial Disease</span></h1><p class="contrib-group"><span itemprop="author">Gr&#x000e1;inne S Gorman</span>, MD, MRCP and <span itemprop="author">Robert W Taylor</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK195854_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK195854_ai__"><div class="contrib half_rhythm"><span itemprop="author">Gr&#x000e1;inne S Gorman</span>, MD, MRCP<div class="affiliation small">Wellcome Trust Centre for Mitochondrial Research<br />Newcastle University<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.eltsacwen@namrog.enniarg" class="oemail">ku.ca.eltsacwen@namrog.enniarg</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert W Taylor</span>, PhD<div class="affiliation small">Wellcome Trust Centre for Mitochondrial Research<br />Newcastle University<br />Newcastle upon Tyne, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.eltsacwen@rolyat.trebor" class="oemail">ku.ca.eltsacwen@rolyat.trebor</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 17, 2014</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="rrm2b-mtddepl.Summary" itemprop="description"><h2 id="_rrm2b-mtddepl_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>RRM2B</i>-related mitochondrial disease can be grouped by disease pathogenesis, <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, and <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> into two major types: mitochondrial DNA (mtDNA) depletion and multiple mtDNA deletions.</p><ul><li class="half_rhythm"><div>Mitochondrial DNA depletion usually manifests as severe multisystem disease (encephalomyopathy with proximal renal tubulopathy) and is often fatal in early life. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div>Multiple mtDNA deletions cause tissue-specific cytochrome <i>c</i> oxidase (COX) deficiency. Inheritance can be either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (with progressive external ophthalmoplegia [PEO] and multisystem involvement manifesting during early childhood/adulthood) or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (with less severe, often tissue-specific manifestations [e.g., chronic PEO] developing in later adulthood).</div></li></ul><p>Other rarer phenotypes are Kearns-Sayre syndrome (KSS) and mitochondrial neurogastrointestinal encephalopathy (MNGIE).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RRM2B</i> pathogenic variants confirms the diagnosis of an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>RRM2B</i>-related mitochondrial disease. The presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> confirms the diagnosis of an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i>-related mitochondrial disease in those suspected of having a late-onset disorder of mtDNA maintenance.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> No cures and few effective treatments exist for any form of mitochondrial disease, including this one. Treatment, which focuses on symptomatic management and supportive care, is best provided by a multidisciplinary team. Management issues for those with systemic involvement may include: nutritional support (gastrointestinal involvement), care by a pediatric nephrologist (renal tubulopathy), care by a pediatric pulmonologist (impaired respiratory function), physical therapy (to maintain strength and mobility and to prevent contractures), care by a pediatric neurologist (seizures), and care by hearing loss specialists (to determine the best habilitation options for sensorineural hearing loss). Management issues for those with PEO may include: ptosis surgery for cosmetic effect and/or symptomatic relief; ECG to screen for significant cardiac conduction defects. For both clinical presentations: aggressive management of fever and infection.</p><p><i>Surveillance:</i> No clinical guidelines specific to <i>RRM2B</i>-related mitochondrial disease are available; however, for those with systemic involvement the following should be considered: regular evaluation of: neurodevelopment, speech, and language; presence/severity of encephalopathy and/or seizures/subclinical status epilepticus; renal function; nutritional status, growth, and body mass index (BMI); and pulmonary function. For those with PEO the following biannual evaluations should be considered: neurologic status; occupational and physical therapy assessments; CBC, electrolytes, liver function (albumin, coagulation factors), liver enzymes (AST, ALT, GGT), blood glucose, and HBA1C; and nutritional status, weight, and body mass index (BMI).</p><p><i>Agents/circumstances to avoid:</i> Specifically: Valproic acid (theoretic risk of precipitating/exacerbating organ failure due to mitochondrial toxicity); metformin (theoretic risk of exacerbating metabolic acidosis); prolonged use of linezolid (reported association with optic and peripheral neuropathy and lactic acidosis due to mitochondrial toxicity); and zidovudine (reported risk of inducing mitochondrial disease by interfering with mtDNA replication). In general: dehydration and prolonged fasting to prevent clinical deterioration.</p><p><i>Evaluation of relatives at risk:</i> If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to clarify the genetic status of at-risk relatives so that those who harbor the pathogenic variant(s) can (1) undergo timely routine surveillance for disease complications and (2) avoid possible precipitating factors.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>RRM2B</i>-related mitochondrial disease can be inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (AR) or an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (AD) manner.</p><ul><li class="half_rhythm"><div>AR inheritance. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (carriers) and are asymptomatic. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>AD inheritance. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals likely have an affected parent; the proportion caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown. The offspring of an affected individual has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and, thus, being symptomatic.</div></li></ul><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for pregnancies at increased risk is possible.</p></div></div><div id="rrm2b-mtddepl.GeneReview_Scope"><h2 id="_rrm2b-mtddepl_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="rrm2b-mtddepl.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK195854/table/rrm2b-mtddepl.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rrm2b-mtddepl.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rrm2b-mtddepl.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i>-Related Mitochondrial Disease: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_rrm2b-mtddepl.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Mitochondrial DNA depletion syndrome (encephalomyopathic form with renal tubulopathy)</div></li><li class="half_rhythm"><div>Mitochondrial neurogastrointestinal encephalopathy</div></li><li class="half_rhythm"><div>Chronic progressive external ophthalmoplegia with multiple mtDNA deletions</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rrm2b-mtddepl.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#rrm2b-mtddepl.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="rrm2b-mtddepl.Diagnosis"><h2 id="_rrm2b-mtddepl_Diagnosis_">Diagnosis</h2><p><i>RRM2B</i>-related mitochondrial disease can, for the most part, be characterized by disease pathogenesis, <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, and <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>:</p><ul><li class="half_rhythm"><div>Mitochondrial DNA (mtDNA) depletion, which usually manifests as severe multisystem disease (encephalomyopathy with proximal renal tubulopathy) and is often fatal in early life. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>]</div></li><li class="half_rhythm"><div>Accumulation of clonally expanded (multiple) mtDNA deletions causing tissue-specific cytochrome <i>c</i> oxidase (COX) deficiency. Inheritance can be <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> (<b>AR</b>) or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> (<b>AD</b>) [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.takata.2011.r92">Takata et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>]:</div><ul><li class="half_rhythm"><div><b>AR.</b> Disease generally manifests during early childhood/adulthood with marked multisystem involvement (chronic progressive external ophthalmoplegia [PEO] and KSS).</div></li><li class="half_rhythm"><div><b>AD.</b> Disease typically develops in later adulthood, is usually less severe, and is often tissue-specific, such as chronic PEO.</div></li></ul></li></ul><p><b><i>RRM2B</i>-related mitochondrial disease should be suspected</b>
<b>in the following</b></p><ul><li class="half_rhythm"><div>Children with:</div><ul><li class="half_rhythm"><div>Myopathy manifesting as muscle hypotonia and weakness, often associated with respiratory insufficiency</div></li><li class="half_rhythm"><div>Gastrointestinal disturbance manifesting as dysmotility</div></li><li class="half_rhythm"><div>Proximal renal tubulopathy with nephrocalcinosis</div></li><li class="half_rhythm"><div>CNS findings including seizures, developmental delay, microcephaly, and hearing loss</div></li><li class="half_rhythm"><div>Lactic acidosis</div></li><li class="half_rhythm"><div>Skeletal muscle tissue showing severe mtDNA depletion and mitochondrial respiratory chain defects</div></li></ul></li><li class="half_rhythm"><div>Adults with:</div><ul><li class="half_rhythm"><div>Progressive external ophthalmoplegia (PEO)</div></li><li class="half_rhythm"><div>Ptosis of variable severity</div></li><li class="half_rhythm"><div>Proximal muscle weakness and/or fatigue</div></li><li class="half_rhythm"><div>Bulbar dysfunction</div></li><li class="half_rhythm"><div>Absent or minimal CNS findings, including ataxia, cognitive dysfunction, and mood disturbance</div></li><li class="half_rhythm"><div>Sensorineural hearing loss (SNHL)</div></li><li class="half_rhythm"><div>Sensory axonal peripheral neuropathy</div></li><li class="half_rhythm"><div>Gastrointestinal problems, including irritable bowel syndrome-like symptoms and low body mass index (BMI)</div></li><li class="half_rhythm"><div>Endocrinopathy (including hypothyroidism, hypoparathyroidism, diabetes mellitus, and hypogonadism)</div></li></ul></li><li class="half_rhythm"><div><b>Individuals with</b>
<a href="/books/n/gene/kss/"><b>Kearns-Sayre syndrome</b></a> when inheritance appears to follow a Mendelian pattern and/or examination of muscle tissue reveals evidence of multiple mtDNA deletions.</div></li><li class="half_rhythm"><div><b>Individuals with</b>
<a href="/books/n/gene/mngie/"><b>mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease</b></a> when plasma thymidine concentration is &#x0003c;3 &#x000b5;mol/L, plasma deoxyuridine concentration &#x0003c;5 &#x000b5;mol/L, thymidine phosphorylase enzyme activity in leukocytes is &#x0003e;10% of the control mean, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not identify <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>TYMP</i> (the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding thymidine phosphorylase).</div></li></ul><p><b>One strategy for establishing the molecular diagnosis of <i>RRM2B</i>-related mitochondrial disease in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> is to perform a skeletal muscle biopsy to evaluate for characteristic histopathologic changes that are only apparent in muscle tissue: cytochrome <i>c</i> oxidase (COX)-deficient fibers and subsarcolemmal mitochondrial accumulation (classic "ragged-red" fibers).</p><p>If the muscle tissue shows evidence of mitochondrial disease, perform (in skeletal muscle) the following:</p><ul><li class="half_rhythm"><div>Quantitative studies of mtDNA copy number for evidence of mtDNA depletion (typically &#x0003c;30% of age- and tissue-matched control samples)</div></li><li class="half_rhythm"><div>Qualitative studies for evidence of clonally expanded multiple mtDNA deletions (<a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, <a class="figpopup" href="/books/NBK195854/table/rrm2b-mtddepl.T.molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figrrm2bmtddeplTmoleculargenetictestin" rid-ob="figobrrm2bmtddeplTmoleculargenetictestin">Table 1</a>)</div></li></ul><p>If a skeletal muscle biopsy cannot be obtained, perform (on DNA extracted from leukocytes) <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the entire <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, including <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a>/<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> boundaries (<a class="figpopup" href="/books/NBK195854/table/rrm2b-mtddepl.T.molecular_genetic_testin/?report=objectonly" target="object" rid-figpopup="figrrm2bmtddeplTmoleculargenetictestin" rid-ob="figobrrm2bmtddeplTmoleculargenetictestin">Table 1</a>).</p><ul><li class="half_rhythm"><div class="half_rhythm">The presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (i.e., <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a>) <i>RRM2B</i> pathogenic variants confirms the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>RRM2B</i>-related mitochondrial disease.</div><div class="half_rhythm">Note: If <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> does not identify <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RRM2B</i> pathogenic variants and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance is suspected, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> should be considered.</div></li><li class="half_rhythm"><div class="half_rhythm">The presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> confirms the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i>-related mitochondrial disease.</div></li></ul><p><b>A different strategy for establishing the molecular diagnosis of <i>RRM2B</i>-related mitochondrial disease in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> is the use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> comprising a number of genes known to disturb mtDNA maintenance (see <a href="#rrm2b-mtddepl.Differential_Diagnosis">Differential Diagnosis</a> for a discussion of some of these disorders).</p><div id="rrm2b-mtddepl.T.molecular_genetic_testin" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>RRM2B</i>-Related Mitochondrial Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK195854/table/rrm2b-mtddepl.T.molecular_genetic_testin/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rrm2b-mtddepl.T.molecular_genetic_testin_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by this Method</th></tr></thead><tbody><tr><td headers="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>RRM2B</i></td><td headers="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_rrm2b-mtddepl.T.molecular_genetic_testin_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="rrm2b-mtddepl.TF.1.1"><p class="no_margin">See <a href="/books/NBK195854/#rrm2b-mtddepl.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#rrm2b-mtddepl.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="rrm2b-mtddepl.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="rrm2b-mtddepl.TF.1.3"><p class="no_margin">Because of the difficulty of detecting small deletions by conventional sequencing strategies, <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> frequency is reported to be &#x0003c;100%.</p></div></dd><dt>4. </dt><dd><div id="rrm2b-mtddepl.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long <i>RRM2B</i> -range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="rrm2b-mtddepl.TF.1.5"><p class="no_margin">No <i>RRM2B</i> deletions have been reported to date.</p></div></dd></dl></div></div></div></div><div id="rrm2b-mtddepl.Clinical_Characteristics"><h2 id="_rrm2b-mtddepl_Clinical_Characteristics_">Clinical Characteristics</h2><div id="rrm2b-mtddepl.Clinical_Description"><h3>Clinical Description</h3><p>Pathogenic variants in <i>RRM2B</i> are associated predominantly with either:</p><ul><li class="half_rhythm"><div class="half_rhythm">Mitochondrial DNA depletion syndrome (encephalomyopathic form with renal tubulopathy), which usually presents as a childhood-onset severe multisystem disease;</div><div class="half_rhythm">OR</div></li><li class="half_rhythm"><div class="half_rhythm">Chronic progressive external ophthalmoplegia with multiple mtDNA deletions, which is usually adult-onset, milder, and often tissue-specific.</div></li></ul><p>However, other phenotypes include <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a> and <a href="/books/n/gene/mngie/">mitochondrial neurogastrointestinal encephalopathy</a> (MNGIE).</p><p><i>RRM2B</i>-related mitochondrial diseases are emerging as an important cause of both pediatric and adult-onset mitochondrial disease. To date, 73 individuals from 42 families with molecularly confirmed <i>RRM2B</i>-related mitochondrial disease have been reported [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.takata.2011.r92">Takata et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</p><p><b>Mitochondrial DNA depletion syndrome (encephalomyopathic form with renal tubulopathy),</b> the most severe form of the disease, is a multisystem disorder associated with severe mtDNA depletion; it has been reported in 15 individuals [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>]. Onset typically occurs in the first six months of life; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children succumb in early childhood.</p><p>Disease characteristics include myopathy manifest as muscle hypotonia (in all 15 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals), weakness associated with respiratory insufficiency (in 10), lactic acidosis (13), failure to thrive and gastrointestinal dysmotility (9), and proximal renal tubulopathy with nephrocalcinosis (9) [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>].</p><p>Central nervous system (CNS) features can include seizures (5 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals), sensorineural hearing loss of varying severity (3), microcephaly (2), cerebral atrophy (1), and generalized central hypomyelination (1).</p><p><b>Chronic progressive external ophthalmoplegia (PEO) with multiple mtDNA deletions.</b> In 31 adults with chronic PEO and multiple mtDNA deletions in muscle in whom mutation of all other genes known to cause this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., <i>POLG</i>, <i>POLG2</i>, <i>SLC25A4</i>, and <i>TWNK</i>) had been excluded, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al [2012]</a>, identified an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i>-related disorder in 24 individuals and an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>RRM2B</i>- related disorder in seven.</p><p>Ptosis and PEO were universal. Extra-ocular neurologic complications were common in adults with genetically confirmed <i>RRM2B</i>-related mitochondrial disease. Also prominent were myopathy (followed by bulbar dysfunction) and fatigue. Sensorineural hearing loss of varying severity and gastrointestinal dysmotility (including irritable bowel syndrome-like symptoms and low body mass index) were also common. Endocrinopathies including diabetes mellitus, hypothyroidism, hypoparathyroidism, and hypogonadism were important additional clinical features.</p><ul><li class="half_rhythm"><div><b>Autosomal dominant inheritance</b></div><ul><li class="half_rhythm"><div>The first individuals reported were from two large, unrelated families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> PEO caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9 (<a class="figpopup" href="/books/NBK195854/table/rrm2b-mtddepl.T.selected_rrm2b_pathogeni/?report=objectonly" target="object" rid-figpopup="figrrm2bmtddeplTselectedrrm2bpathogeni" rid-ob="figobrrm2bmtddeplTselectedrrm2bpathogeni">c.979C &#x0003e;T</a>) predicting p.Arg327Ter) that resulted in truncation of the translated p53R2 (see <a href="#rrm2b-mtddepl.Molecular_Genetics">Molecular Genetics</a>, <b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a></b>) protein [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>]. In these families the earliest onset was in the third decade (average age 46 years). The cardinal features were PEO and ptosis as well as ataxia, cognitive dysfunction, exercise intolerance, sensorineural hearing loss, mood disturbance, and peripheral neuropathy.</div></li><li class="half_rhythm"><div>More recently, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>RRM2B</i> pathogenic variants have been shown to be frequent in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> PEO with muscle-restricted multiple mtDNA deletions [<a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is a milder myopathy with proximal muscle weakness, bulbar dysfunction, and fatigue. Mean age of disease onset is 46 years.</div></li></ul></li><li class="half_rhythm"><div><b>Autosomal recessive inheritance</b></div><ul><li class="half_rhythm"><div>In children with <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>RRM2B</i> pathogenic variants, disease onset was at a mean age of seven years. The predominantly myopathic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of PEO, ptosis, proximal muscle weakness, and bulbar dysfunction was more severe than the multisystem disorder observed in individuals with a heterozygous <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</div></li><li class="half_rhythm"><div>Additionally, a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>RRM2B</i> has been described in a 43-year-old man who presented at age 16 years with progressive hearing loss followed by the insidious onset of PEO, muscle weakness, retinopathy, and a major depressive disorder, findings that further extend the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#rrm2b-mtddepl.REF.takata.2011.r92">Takata et al 2011</a>].</div></li></ul></li></ul><p><a href="/books/n/gene/mngie/"><b>Mitochondrial neurogastrointestinal encephalopathy</b></a>
<b>(MNGIE)</b> has been reported in a woman age 42 years with <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants and mtDNA depletion in clinically relevant tissues [<a class="bk_pop" href="#rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani et al 2009</a>]. For more information about this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, see <a href="/books/n/gene/mngie/">MNGIE</a>.</p><p><a href="/books/n/gene/kss/"><b>Kearns-Sayre syndrome</b></a>
<b>(KSS).</b>
<i>RRM2B</i> pathogenic variants have been identified in one individual with onset before age 20 years of PEO-plus / Kearns-Sayre syndrome (PEO, pigmentary retinopathy, sensorineural hearing loss, and increased CSF protein), which is similar to single mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> disorders [<a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>].</p></div><div id="rrm2b-mtddepl.GenotypePhenotype_Correlat"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations cannot be clearly defined in <i>RRM2B</i>-related mitochondrial disease. <i>RRM2B</i> pathogenic variants have been associated with both <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family) and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> mitochondrial disease characterized by either <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> mtDNA depletion syndrome (which is associated with a quantitative loss of mtDNA copies) or autosomal recessive and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pathogenic variants (which cause the accumulation of multiple mtDNA deletions in post-mitotic tissues).</p><p>The same <i>RRM2B</i> pathogenic variants are associated with varied phenotypic severity depending on whether they are <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> or <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>.</p><p>Mitochondrial DNA depletion is commonly seen in children with clinically severe <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in genes encoding proteins essential to mtDNA maintenance [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>]; however, it has also been observed in one adult with biallelic <i>RRM2B</i> pathogenic variants [<a class="bk_pop" href="#rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.takata.2011.r92">Takata et al 2011</a>]. Thus, <i>RRM2B</i>-related mtDNA depletion can potentially cause a relatively mild clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="rrm2b-mtddepl.Penetrance"><h3>Penetrance</h3><p>The clinical manifestations of <i>RRM2B</i>-related disorders are similar in males and females.</p></div><div id="rrm2b-mtddepl.Prevalence"><h3>Prevalence</h3><p>The prevalence of <i>RRM2B-</i>related mitochondrial disorders is unknown.</p><p>Pathogenic variants in <i>RRM2B</i> are now increasingly recognized as an important cause of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> mitochondrial disease in both adults and children and represent the third most common cause of multiple mtDNA deletions in adults, following pathogenic variants in <i>POLG</i> (encoding pol &#x003b3;) and <i>TWNK</i> (encoding the Twinkle helicase) [<a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</p></div></div><div id="rrm2b-mtddepl.Genetically_Related_Alleli"><h2 id="_rrm2b-mtddepl_Genetically_Related_Alleli_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>RRM2B</i>.</p></div><div id="rrm2b-mtddepl.Differential_Diagnosis"><h2 id="_rrm2b-mtddepl_Differential_Diagnosis_">Differential Diagnosis</h2><p>The first reported human diseases attributed to mutation of <i>RRM2B</i> were associated with a quantitative loss of mtDNA copies &#x02013; the so-called mtDNA depletion syndromes. To date, mutation of the following nine nuclear genes has been associated with mtDNA depletion syndromes: <i>DGUOK</i>, <i>MPV17</i>, <i>TWNK</i>, <i>POLG</i>, <i>SUCLA2</i>, <i>SUCLG1</i>, <i>TK2</i>, <i>TYMP</i>, and <i>RRM2B.</i> Clinical characteristics (and the associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>) can be summarized as [<a class="bk_pop" href="#rrm2b-mtddepl.REF.suomalainen.2010.429">Suomalainen &#x00026; Isohanni 2010</a>]:</p><ul><li class="half_rhythm"><div>Myopathic (<a href="/books/n/gene/tk2-mtddepl/"><i>TK2</i></a>)</div></li><li class="half_rhythm"><div>Hepatocerebral (<a href="/books/n/gene/dguok-mtddepl/"><i>DGUOK</i></a>, <a href="/books/n/gene/mpv17-mtdep/"><i>MPV17</i></a>, <a href="/books/n/gene/alpers/"><i>POLG</i></a>, and <i>TWNK</i>)</div></li><li class="half_rhythm"><div>Encephalomyopathic (<a href="/books/n/gene/sucla2-def/"><i>SUCLA2</i></a>, <a href="/books/n/gene/suclg1-mtddepl/"><i>SUCLG1</i></a>, <a href="/books/n/gene/mngie/"><i>TYMP</i></a>, and <i>RRM2B</i>)</div></li></ul><p>See <a href="http://www.omim.org/phenotypicSeries/PS603041" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mitochondrial DNA depletion syndrome: OMIM Phenotypic Series</a> to view genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p><p><b>Comparison of <i>RRM2B-</i>related mitochondrial disorders with other mtDNA depletion and mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> syndromes</b></p><p><b>In children.</b> Hypotonia, lactic acidosis, and proximal renal tubulopathy in association with mitochondrial respiratory chain defects and severe mtDNA depletion in skeletal muscle should prompt testing of <i>RRM2B</i> before other nuclear-encoded genes (in which muscle weakness is the predominant clinical feature). In children with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>RRM2B</i> pathogenic variants gastrointestinal disturbance is often severe, but CNS involvement is less common than in other <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> mitochondrial disorders [<a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</p><p><b>In adults.</b> Progressive external ophthalmoplegia (PEO), ptosis, and proximal muscle weakness are the predominant clinical characteristics seen with mutation of <i>POLG</i> and <i>TWNK</i> (encoding twinkle), the two most common causes of multiple mtDNA deletions. In contrast, bulbar dysfunction, sensorineural hearing loss, and gastrointestinal problems (including irritable bowel syndrome-like symptoms and low body mass index) appear to occur more often in adults with mutation of <i>RRM2B</i> than mutation of <i>POLG</i> or <i>TWNK</i>. Thus, in adults the presence of PEO, multiple mtDNA deletions in skeletal muscle, bulbar dysfunction, sensorineural hearing loss, and gastrointestinal problems in the absence of overt CNS features supports testing of <i>RRM2B</i> before <i>POLG</i> and <i>TWNK</i>.</p><p><a href="/books/n/gene/kss/"><b>Kearns-Sayre syndrome</b></a>
<b>(KSS).</b>
<i>RRM2B</i> testing should be considered when the pattern of inheritance appears to be Mendelian and/or evidence of multiple mtDNA deletions is observed on muscle biopsy.</p><p><a href="/books/n/gene/mngie/"><b>Mitochondrial neurogastrointestinal encephalopathy</b></a>
<b>(MNGIE).</b>
<i>RRM2B</i> testing should be considered in individuals with MNGIE if deoxyuridine and thymidine levels in both blood and urine are negative, thymidine phosphorylase activity is normal in white cells and platelets, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> does not identify causative pathogenic variants in <i>TYMP</i>.</p></div><div id="rrm2b-mtddepl.Management"><h2 id="_rrm2b-mtddepl_Management_">Management</h2><div id="rrm2b-mtddepl.Evaluations_Following_Init"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>RRM2B</i>-related mitochondrial disease, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Comprehensive clinical examination and neurology consultation that includes measures of functional neurologic status</div></li><li class="half_rhythm"><div>Formal developmental evaluation (particularly in a child with the encephalomyopathic form with renal tubulopathy)</div></li><li class="half_rhythm"><div>Formal assessment of vision and hearing</div></li><li class="half_rhythm"><div>Brain MRI and electroencephalogram (EEG) in individuals with encephalopathy and/or seizures. Note: these may be normal with certain <i>RRM2B</i>-related mitochondrial disease phenotypes.</div></li><li class="half_rhythm"><div>Nutritional assessment</div></li><li class="half_rhythm"><div>Speech and language assessment</div></li><li class="half_rhythm"><div>Physical therapy assessment</div></li><li class="half_rhythm"><div>Occupational therapy assessment</div></li><li class="half_rhythm"><div>Pulmonary function testing</div></li><li class="half_rhythm"><div>For those with Kearns-Sayre syndrome, cardiac evaluation to include electrocardiogram (ECG) and/or echocardiogram</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="rrm2b-mtddepl.Treatment_of_Manifestation"><h3>Treatment of Manifestations</h3><p>Detailed evaluations are outlined in <a href="http://www.newcastle-mitochondria.com/clinical-professional-home-page/clinical-publications/clinical-guidelines/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Wellcome Trust Centre for Mitochondrial Research Clinical Guidelines</a>.</p><p>To date, there are no known cures and few effective treatments for any forms of mitochondrial disease, including <i>RRM2B</i>-related mitochondrial disease. Treatment modalities currently focus on symptomatic management and supportive care, and are best implemented by a multidisciplinary team.</p><p>General management guidelines for those with systemic involvement:</p><ul><li class="half_rhythm"><div>Nutritional support (e.g., nasogastric tube, gastrostomy) as needed for significant gastrointestinal involvement</div></li><li class="half_rhythm"><div>Early referral to a pediatric renal specialist for those with proximal renal tubulopathy</div></li><li class="half_rhythm"><div>Early referral to a pediatric pulmonologist for children with evidence of reduced respiratory function. Management may include consideration of tracheostomy and artificial ventilation.</div></li><li class="half_rhythm"><div>Physical therapy to maintain muscle strength and mobility and to prevent contractures</div></li><li class="half_rhythm"><div>Referral to a pediatric neurologist for seizure management. Of note, seizures may be refractory to treatment.</div></li><li class="half_rhythm"><div>Referral to hearing loss specialists to determine the best habilitation options for sensorineural hearing loss (see <a href="/books/n/gene/deafness-overview/">Hereditary Hearing Loss and Deafness</a> for discussion of management issues)</div></li></ul><p>General management guidelines for those with progressive external ophthalmoplegia (PEO):</p><ul><li class="half_rhythm"><div>Ptosis surgery for cosmesis and/or symptomatic relief in those with good residual orbicularis oculi muscle strength</div></li><li class="half_rhythm"><div>ECG in all individuals with PEO to screen for significant cardiac conduction defects which may warrant placement of a pacemaker, particularly in those with the <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a> <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></div></li></ul><p>General management guidelines for both those with systemic involvement and those with PEO:</p><ul><li class="half_rhythm"><div>Aggressive management of fever and infection</div></li></ul></div><div id="rrm2b-mtddepl.Surveillance"><h3>Surveillance</h3><p>No clinical guidelines specific to <i>RRM2B</i>-related mitochondrial disease are available; however, detailed evaluations are outlined in <a href="http://www.newcastle-mitochondria.com/clinical-professional-home-page/clinical-publications/clinical-guidelines/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Wellcome Trust Centre for Mitochondrial Research Clinical Guidelines</a>.</p><p>The following evaluations should be considered:</p><p><b><i>RRM2B</i>-related mitochondrial DNA depletion syndrome (encephalo-myopathic form with renal tubulopathy)</b></p><ul><li class="half_rhythm"><div>Regular assessments of neurodevelopment, speech, and language</div></li><li class="half_rhythm"><div>Regular evaluations by a pediatric neurologist to evaluate for the presence and/or severity of encephalopathy, with consideration of EEG and video EEG monitoring to determine presence of seizures and/or subclinical status epilepticus</div></li><li class="half_rhythm"><div>Regular evaluation by a pediatric renal specialist, including assessment of renal function (electrolytes in blood and urine and urine analysis)</div></li><li class="half_rhythm"><div>Routine assessment of nutritional status, growth, and body mass index (BMI)</div></li><li class="half_rhythm"><div>Regular pulmonary function testing including monitoring of blood gases for early detection of respiratory compromise</div></li></ul><p><b><i>RRM2B</i>-related mitochondrial DNA depletion syndrome and mitochondrial neurogastrointestinal encephalopathy</b></p><ul><li class="half_rhythm"><div>Biannual:</div><ul><li class="half_rhythm"><div>Comprehensive neurology consultation and clinical examination to include measures of functional neurologic status</div></li><li class="half_rhythm"><div>Occupational therapy and physical therapy assessments</div></li><li class="half_rhythm"><div>CBC, electrolytes, liver function (albumin, coagulation factors), liver enzymes (AST, ALT, GGT), blood glucose, and HBA1C</div></li></ul></li><li class="half_rhythm"><div>Annual pulmonary function testing including assessment of blood gases to monitor for early respiratory compromise</div></li><li class="half_rhythm"><div>Routine assessment of nutritional status, weight gain, and BMI, including regular review with speech and language therapist with consideration of gastrostomy as needed for nutritional support</div></li><li class="half_rhythm"><div>Imaging and diagnostic procedures including EEG, ECG, and brain MRI as indicated by clinical findings and rate of disease progression</div></li></ul><p><b><i>RRM2B</i>-related multiple mtDNA deletions with external ophthalmoplegia</b></p><p>Care will be directed by clinical findings. The following general evaluations are recommended:</p><ul><li class="half_rhythm"><div>Biannual:</div><ul><li class="half_rhythm"><div>Comprehensive neurology consultation and clinical examination to include measures of functional neurologic status</div></li><li class="half_rhythm"><div>Occupational therapy and physical therapy assessments</div></li><li class="half_rhythm"><div>CBC, electrolytes, liver function (albumin, coagulation factors), liver enzymes (AST, ALT, GGT), blood glucose, and HBA1C</div></li></ul></li><li class="half_rhythm"><div>Annual pulmonary function testing including assessment of blood gases to monitor for early respiratory compromise</div></li><li class="half_rhythm"><div>Routine assessment of nutritional status, weight gain and BMI, biannually</div></li><li class="half_rhythm"><div>Imaging and diagnostic procedures to include EEG, ECG, and MRI brain- as indicated by clinical findings and rate of disease progression</div></li><li class="half_rhythm"><div>ECG advised biannually (KSS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</div></li></ul></div><div id="rrm2b-mtddepl.AgentsCircumstances_to_Avo"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Valproic acid (commonly used for seizures and known to interfere with beta-oxidation) because it is considered to be a mitochondrial toxin with a theoretic risk of precipitating/exacerbating organ failure</div></li><li class="half_rhythm"><div>Metformin (used to treat diabetes mellitus) because of the theoretic risk of exacerbating metabolic acidosis</div></li><li class="half_rhythm"><div>Prolonged use of linezolid (an antibiotic used to treat <i>S. aureus</i> infections) because of the reported association with optic and peripheral neuropathy and lactic acidosis due to mitochondrial toxicity</div></li><li class="half_rhythm"><div>Zidovudine (an antiretroviral nucleoside analog reverse transcriptase used to treat HIV) because of the reported risk of inducing mitochondrial disease by interfering with mtDNA replication</div></li><li class="half_rhythm"><div>Dehydration and prolonged fasting, which can lead to clinical deterioration</div></li></ul></div><div id="rrm2b-mtddepl.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, it is appropriate to clarify the genetic status of at-risk relatives so that those who harbor the pathogenic variant(s) can (1) undergo timely routine <a href="#rrm2b-mtddepl.Surveillance">surveillance</a> for disease complications and (2) <a href="#rrm2b-mtddepl.AgentsCircumstances_to_Avo">avoid possible precipitating factors</a>.</p><p>See <a href="#rrm2b-mtddepl.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="rrm2b-mtddepl.Therapies_Under_Investigat"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="rrm2b-mtddepl.Genetic_Counseling"><h2 id="_rrm2b-mtddepl_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="rrm2b-mtddepl.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>RRM2B</i>-related mitochondrial DNA depletion syndrome (encephalomyopathic form with renal tubulopathy) and <i>RRM2B</i>-related mitochondrial neurogastrointestinal encephalopathy are inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><i>RRM2B</i>-related chronic progressive external ophthalmoplegia with multiple mtDNA deletions can be inherited in either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="rrm2b-mtddepl.Autosomal_Recessive_Inheri"><h3>Autosomal Recessive Inheritance</h3><div id="rrm2b-mtddepl.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals with <i>RRM2B</i>-related mitochondrial DNA depletion syndrome, (encephalomyopathic form with renal tubulopathy) are not known to reproduce.</div></li><li class="half_rhythm"><div>The offspring of individuals with less severe manifestations of <i>RRM2B</i>-related disorders are obligate heterozygotes for an <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="rrm2b-mtddepl.Carrier_Heterozygote_Detec"><h4>Carrier (Heterozygote) Detection</h4><p>Carrier testing for at-risk family members is possible if the pathogenic variants in the family have been identified.</p></div></div><div id="rrm2b-mtddepl.Autosomal_Dominant_Inherit"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i>-related chronic progressive external ophthalmoplegia with multiple mtDNA deletions likely have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; the proportion resulting from <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> in whom mutation apparently occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> include determining the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>At conception, if a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has an <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib has a 50% chance of inheriting the pathogenic variant.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of individuals with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i>-related disorder have a 50% chance of inheriting the <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the status of the proband's parents.</p></div><div id="rrm2b-mtddepl.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#rrm2b-mtddepl.Evaluation_of_Relatives_at">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="rrm2b-mtddepl.Prenatal_Testing_and_Preim"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>RRM2B</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>RRM2B</i>-related mitochondrial disease are possible.</p></div></div><div id="rrm2b-mtddepl.Resources"><h2 id="_rrm2b-mtddepl_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Mito Foundation (formerly the Australian Mitochondrial Disease Foundation)</b></div><div>21 Mary Street</div><div>Suite 3</div><div>Surry Hills New South Wales 2010</div><div>Australia</div><div><b>Phone:</b> 61-1-300-977-180</div><div><b>Fax:</b> 61-2-9999-3474</div><div><b>Email:</b> info@mito.org.au</div><div><a href="https://www.mito.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mito.org.au</a></div></li><li class="half_rhythm"><div><b>The Lily Foundation</b></div><div>31 Warren Park</div><div>Surrey CR6 9LD</div><div>United Kingdom</div><div><b>Phone:</b> 07947 257247</div><div><b>Fax:</b> 01883 623799</div><div><b>Email:</b> liz@thelilyfoundation.org.uk</div><div><a href="http://www.thelilyfoundation.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.thelilyfoundation.org.uk</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li><li class="half_rhythm"><div><b>Mitochondrial Disease Registry and Tissue Bank</b></div><div>Massachusetts General Hospital</div><div>185 Cambridge Street</div><div>Simches Research Building 5-238</div><div>Boston MA 02114</div><div><b>Phone:</b> 617-726-5718</div><div><b>Fax:</b> 617-724-9620</div><div><b>Email:</b> nslate@partners.org</div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: North American Mitochondrial Disease Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/namdc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="rrm2b-mtddepl.Molecular_Genetics"><h2 id="_rrm2b-mtddepl_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="rrm2b-mtddepl.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>RRM2B-Related Mitochondrial Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK195854/table/rrm2b-mtddepl.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rrm2b-mtddepl.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/50484" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>RRM2B</i></a></td><td headers="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=50484" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">8q22<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q7LG56" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ribonucleoside-diphosphate reductase subunit M2 B</a></td><td headers="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=RRM2B" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RRM2B</a></td><td headers="hd_b_rrm2b-mtddepl.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=RRM2B[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">RRM2B</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="rrm2b-mtddepl.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="rrm2b-mtddepl.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for RRM2B-Related Mitochondrial Disease (<a href="/omim/604712,612075,613077" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK195854/table/rrm2b-mtddepl.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rrm2b-mtddepl.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604712" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604712</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RIBONUCLEOTIDE REDUCTASE, M2 B; RRM2B</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612075" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612075</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); MTDPS8A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613077" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613077</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>RRM2B</i>, a nuclear-encoded mitochondrial maintenance <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, comprises nine coding exons. Alternate <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> results in multiple transcript variants (see <a href="/books/NBK195854/#rrm2b-mtddepl.molgen.TA">Table A</a>). The longest known transcript variant (<a href="/nuccore/NM_015713.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015713.4</a> ) encodes a 351-amino acid protein (molecular weight 37 kd). For a detailed summary of gene and protein information, see <a href="/books/NBK195854/#rrm2b-mtddepl.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, 73 individuals from 42 families have been reported to harbor:</p><ul><li class="half_rhythm"><div>17 different <i>RRM2B</i> pathogenic variants in mtDNA depletion syndrome [<a class="bk_pop" href="#rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon et al 2007</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein et al 2008</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>];</div></li><li class="half_rhythm"><div>22 different <i>RRM2B</i> pathogenic variants in mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> disorders [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.takata.2011.r92">Takata et al 2011</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</div></li></ul><p>The majority of reported <i>RRM2B</i> pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. Spliced transcript variants have also been described [<a class="bk_pop" href="#rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola et al 2009</a>].</p><p>Identification of truncating pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9 in unrelated individuals with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> PEO has shown that the mutated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> escapes <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> mediated decay and results in a truncated protein that has been postulated to cause a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> or <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> effect on the heterotetrameric structure of the RNR enzyme, identifying exon 9 as a mutation <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.fratter.2011.2032">Fratter et al 2011</a>].</p><div id="rrm2b-mtddepl.T.selected_rrm2b_pathogeni" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>RRM2B</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK195854/table/rrm2b-mtddepl.T.selected_rrm2b_pathogeni/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__rrm2b-mtddepl.T.selected_rrm2b_pathogeni_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.48G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Glu16Glu)&#x000a0;<sup>2</sup></td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_3" rowspan="36" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_015713.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015713<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="/protein/NP_056528.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056528<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.121C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg41Trp</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.122G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg41Gln</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.122G&#x0003e;C</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg41Pro</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.190T&#x0003e;C</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp64Arg</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.208G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp70Asn</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.253_255delGAG</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu85del</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.322-2A&#x0003e;C<br />(IVS3-2A&#x0003e;C)</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.322-2A&#x0003e;G<br />(IVS3-2A&#x0003e;G)</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.328C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg110Cys</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.329G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg110His</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.97C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro33Ser</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.362G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg121His</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.368T&#x0003e;C</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe123Ser</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.391G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu131Lys</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.431C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr144Ile</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.556A&#x0003e;G</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg186Gly</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.580G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu194Lys</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.581A&#x0003e;G</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu194Gly</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.583G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly195Arg</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.584delG</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly195GlufsTer14</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.606T&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Phe202Leu</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.632G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg211Lys</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.686G&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly229Val</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.671T&#x0003e;G</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ile224Ser</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.707G&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys236Phe</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.817G&#x0003e;A</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly273Ser</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.846G&#x0003e;C</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met282Ile</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.850C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln284Ter</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.920delA</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn307IlefsTer11</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.949T&#x0003e;G</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu317Val</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.950delT</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu317Ter</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.952G&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu318Ter</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.965dupA</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn322LysfsTer4</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.979C&#x0003e;T</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg327Ter</td></tr><tr><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1046C&#x0003e;G</td><td headers="hd_h_rrm2b-mtddepl.T.selected_rrm2b_pathogeni_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala349Gly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="rrm2b-mtddepl.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="rrm2b-mtddepl.TF.2.2"><p class="no_margin">Evidence to support pathogenicity includes aberrant <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a>, partial <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> retention, and premature termination of translation &#x02013; predicting absence of any functional protein from this <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RRM2B</i> encodes <a href="http://www.uniprot.org/uniprot/Q7LG56" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ribonucleoside-diphosphate reductase subunit M2 B</a>, the p53-inducible small subunit (p53R2) of ribonucleotide reductase (RNR), a heterotetrameric enzyme that catalyzes <i>de novo</i> syntheses of dNTPs by direct reduction of ribonucleoside diphosphates to their corresponding deoxyribonucleoside diphosphates. This process supplements the dNTPs produced by the mitochondrial dNTP salvage pathway that is essential for mtDNA synthesis (and in which defects cause many of the mtDNA depletion syndromes [<a class="bk_pop" href="#rrm2b-mtddepl.REF.rahman.2009.3">Rahman &#x00026; Poulton 2009</a>]. Transcription of <i>RRM2B</i> is tightly regulated by the tumor suppressor protein p53.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>RRM2B</i> pathogenic variants result in disruption of mtDNA maintenance (replication and repair), leading to qualitative (accumulation of multiple mtDNA deletions) and/or quantitative (depletion of mtDNA copy number) downstream mitochondrial <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> effects.</p><p>Adult-onset chronic progressive external ophthalmoplegia (CPEO)/multiple mtDNA <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> disorders are associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>RRM2B</i> pathogenic variants. To further understand the functional consequence of adult-onset CPEO/multiple mtDNA deletion disorders associated with both autosomal recessive and autosomal dominant <i>RRM2B</i> pathogenic variants, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al [2011]</a> mapped the positions of the mutated amino acids on the tertiary p53R2 structure [<a class="bk_pop" href="#rrm2b-mtddepl.REF.smith.2009.11134">Smith et al 2009</a>]. Many of the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> pathogenic variants identified appear likely to affect the iron-binding properties of p53R2, and hence impair the catalytic capability of the functional heterotetramer (two p53R2 subunits and two R1 subunits). Gly195, Phe202, and Ile224 are located around the iron-binding pocket. The effect of p.Phe202Leu may be orchestrated through subtle hydrophobic contacts; the effect of amino acids Gly195 and Ile224 is less subtle. Because p.Gly195Arg and p.Ile224Ser are positioned adjacent to amino acids that contribute to the iron coordination environment, substitutions at these two locations influence their amino acid neighbors and alter the coordination of the iron atom(s).</p><p>Previous molecular modeling indicated that p.Arg41Gln prevents formation of a salt bridge which is important in the conformational changes that control iron binding [<a class="bk_pop" href="#rrm2b-mtddepl.REF.smith.2009.11134">Smith et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>]. The variant p.Arg41Trp is also predicted to prevent formation of this salt bridge. Arg211 forms a salt bridge to Glu85, which is thought to be important in stabilizing the di-iron form [<a class="bk_pop" href="#rrm2b-mtddepl.REF.smith.2009.11134">Smith et al 2009</a>, <a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly et al 2011</a>] and, therefore, p.Arg211Lys may also destabilize the di-iron subunit.</p><p>Thr144, Arg186, Thr218, and Gly273 are all located at the end of &#x02013; or, in the case of Gly273, between &#x02013; &#x003b1;-helices and appear to stabilize the orientation of the helices. Mutation of these four amino acids may reduce protein folding efficiency and is associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disease [<a class="bk_pop" href="#rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly et al 2012</a>].</p><p>The effect of the p.Asp70Asn <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot readily be predicted, as Asp70 lies in a poorly understood region of the protein between two helices.</p><p>The variant p.Ala349Gly could not be modeled because the crystal structure does not include the C-terminal portion of the protein. However, Ala349 is located within a conserved heptapeptide (amino acids 345-351) required for interaction with the R1 subunit [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>], and loss of this heptapeptide has been proposed as the pathologic basis of the <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 9 truncating pathogenic variants [<a class="bk_pop" href="#rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa et al 2009</a>].</p></div><div id="rrm2b-mtddepl.References"><h2 id="_rrm2b-mtddepl_References_">References</h2><div id="rrm2b-mtddepl.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.achamroschitz.2009.300">Acham-Roschitz B, Plecko B, Lindbichler F, Bittner R, Mache CJ, Sperl W, Mayr JA. A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. <span><span class="ref-journal">Mol Genet Metab. </span>2009;<span class="ref-vol">98</span>:300–4.</span> [<a href="/pubmed/19616983" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19616983</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.bornstein.2008.453">Bornstein B, Area E, Flanigan KM, Ganesh J, Jayakar P, Swoboda KJ, Coku J, Naini A, Shanske S, Tanji K, Hirano M, DiMauro S. Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. <span><span class="ref-journal">Neuromuscul Disord. </span>2008;<span class="ref-vol">18</span>:453–9.</span> [<a href="/pmc/articles/PMC3891825/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3891825</span></a>] [<a href="/pubmed/18504129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18504129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.bourdon.2007.776">Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chr&#x000e9;tien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, Nakamura Y, Munnich A, R&#x000f6;tig A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:776–80.</span> [<a href="/pubmed/17486094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17486094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.fratter.2011.2032">Fratter C, Raman P, Alston CL, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Hanna MG, Poulton J, Brierley C, Staunton TG, Turnpenny PD, Schaefer AM, Chinnery PF, Horvath R, Turnbull DM, Gorman GS, Taylor RW. RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:2032–4.</span> [<a href="/pmc/articles/PMC3109879/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3109879</span></a>] [<a href="/pubmed/21646632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21646632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.kollberg.2009.147">Kollberg G, Darin N, Benan K, Moslemi AR, Lindal S, Tulinius M, Oldfors A, Holme E. A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. <span><span class="ref-journal">Neuromuscul Disord. </span>2009;<span class="ref-vol">19</span>:147–50.</span> [<a href="/pubmed/19138848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19138848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.pitceathly.2011.610">Pitceathly RD, Fassone E, Taanman JW, Sadowski M, Fratter C, Mudanohwo EE, Woodward CE, Sweeney MG, Holton JL, Hanna MG, Rahman S. Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:610–7.</span> [<a href="/pubmed/21378381" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21378381</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.pitceathly.2012.3392">Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z, Deschauer M, Pohl U, Roberts ME, Jackson MC, Halfpenny CA, Turnpenny PD, Lunt PW, Hanna MG, Schaefer AM, McFarland R, Horvath R, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:3392–403.</span> [<a href="/pmc/articles/PMC3501970/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3501970</span></a>] [<a href="/pubmed/23107649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23107649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.rahman.2009.3">Rahman S, Poulton J. Diagnosis of mitochondrial DNA depletion syndromes. <span><span class="ref-journal">Arch Dis Child. </span>2009;<span class="ref-vol">94</span>:3–5.</span> [<a href="/pubmed/19103785" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19103785</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.shaibani.2009.1028">Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Wong LJ, Shinawi M. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. <span><span class="ref-journal">Arch Neurol. </span>2009;<span class="ref-vol">66</span>:1028–32.</span> [<a href="/pmc/articles/PMC2747647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2747647</span></a>] [<a href="/pubmed/19667227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19667227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.smith.2009.11134">Smith P, Zhou B, Ho N, Yuan YC, Su L, Tsai SC, Yen Y. 2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase . <span><span class="ref-journal">Biochemistry. </span>2009;<span class="ref-vol">48</span>:11134–41.</span> [<a href="/pmc/articles/PMC2844085/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2844085</span></a>] [<a href="/pubmed/19728742" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19728742</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.spinazzola.2009.143">Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, Giordano I, Meznaric-Petrusa M, Baruffini E, Ferrero I, Zeviani M. Clinical and molecular features of mitochondrial DNA depletion syndromes. <span><span class="ref-journal">J Inherit Metab Dis. </span>2009;<span class="ref-vol">32</span>:143–58.</span> [<a href="/pubmed/19125351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19125351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.suomalainen.2010.429">Suomalainen A, Isohanni P. Mitochondrial DNA depletion syndromes--many genes, common mechanisms. <span><span class="ref-journal">Neuromuscul Disord. </span>2010;<span class="ref-vol">20</span>:429–37.</span> [<a href="/pubmed/20444604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20444604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.takata.2011.r92">Takata A, Kato M, Nakamura M, Yoshikawa T, Kanba S, Sano A, Kato T. Exome sequencing identifies a novel missense variant in RRM2B associated with autosomal recessive progressive external ophthalmoplegia. <span><span class="ref-journal">Genome Biol. </span>2011;<span class="ref-vol">12</span>:R92.</span> [<a href="/pmc/articles/PMC3308055/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3308055</span></a>] [<a href="/pubmed/21951382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21951382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="rrm2b-mtddepl.REF.tyynismaa.2009.290">Tyynismaa H, Ylikallio E, Patel M, Molnar MJ, Haller RG, Suomalainen A. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:290–5.</span> [<a href="/pmc/articles/PMC2725268/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2725268</span></a>] [<a href="/pubmed/19664747" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19664747</span></a>]</div></li></ul></div></div><div id="rrm2b-mtddepl.Chapter_Notes"><h2 id="_rrm2b-mtddepl_Chapter_Notes_">Chapter Notes</h2><div id="rrm2b-mtddepl.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.mitoresearch.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>Wellcome Trust Centre for Mitochondrial Research</b></a></p><p>Institute for Ageing and Health<br />Newcastle University<br />Medical School<br />Framlington Place<br />Newcastle upon Tyne<br />NE2 4HH<br />Telephone: 0191 222 3009<br />Fax:0191 222 5685</p></div><div id="rrm2b-mtddepl.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>17 April 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>31 May 2013 (gg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK195854</span><span class="label">PMID: <a href="/pubmed/24741716" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24741716</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/rpe65-lca/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/refsum/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK195854&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK195854/?report=reader">PubReader</a></li><li><a href="/books/NBK195854/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK195854" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK195854" style="display:none" title="Cite this Page"><div class="bk_tt">Gorman GS, Taylor RW. RRM2B-Related Mitochondrial Disease. 2014 Apr 17. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK195854/pdf/Bookshelf_NBK195854.pdf">PDF version of this page</a> (461K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#rrm2b-mtddepl.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#rrm2b-mtddepl.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#rrm2b-mtddepl.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#rrm2b-mtddepl.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#rrm2b-mtddepl.Genetically_Related_Alleli" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#rrm2b-mtddepl.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#rrm2b-mtddepl.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#rrm2b-mtddepl.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#rrm2b-mtddepl.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#rrm2b-mtddepl.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#rrm2b-mtddepl.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#rrm2b-mtddepl.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=50484[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">RRM2B</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3084176" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3084176" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3084176" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3084176" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301403" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial Disorders Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chinnery PF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301382" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA Deletion Syndromes</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mitochondrial DNA Deletion Syndromes<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Goldstein A, Falk MJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593919" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPV17-</i>Related Mitochondrial DNA Maintenance Defect</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MPV17-</i>Related Mitochondrial DNA Maintenance Defect<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Wang J, Dai H, Almannai M, Scaglia F, Craigen WJ, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301411" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> MELAS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">El-Hattab AW, Almannai M, Scaglia F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24741716" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24741716" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0411ce75f66d18aae914fa">RRM2B-Related Mitochondrial Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">RRM2B-Related Mitochondrial Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:50:06-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B9934E0402BA10000000006050233&amp;ncbi_session=CE8B9934E0411CE1_1541SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK195854%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK195854&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK195854/&amp;ncbi_pagename=RRM2B-Related Mitochondrial Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B9934E0411CE1_1541SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>